Skip to main content

Table 2 Main studies on radiomics/AI imaging applications for primary treatments with curative intent in the setting of prostate cancer management (one example for each main potential application is proposed)

From: Beyond diagnosis: is there a role for radiomics in prostate cancer management?

First author [reference number]

Publication year

Country

Treatment

Aim

Design

Sample size

Imaging modality

Main outcome

Potential impact

Künzel [32]

2021

Germany

RT

Autonomous treatment planning

Prospective, single-centre

1

MRI (AI)

Feasibility of autonomous treatment planning for adaptive MRIgRT proven

Reduction of time to treatment and RO workload. Potential first step toward real-time RT

Shiradkar [35]

2016

USA

RT

Targeted focal treatment planning

Retrospective, multicentre

23

MRI (radiomics)

Radiomics framework showed reduction in dosage to OARs and boosted dose to index lesions

Decision support framework for RO to elaborate more effective and targeted treatments

Rossi [48]

2018

The Netherlands

RT

Toxicity prediction

Retrospective, multicentre

351

Dose distributions (dosiomics)

Dosiomics showed an added value for the prediction of RT toxicity, statistically significant for GI toxicity compared to NCTP

More reliable prediction of adverse events might aid RO in treatment planning

Abdollahi [38]

2019

Iran

RT

Prediction of treatment response

Retrospective, single-centre

33

MRI (radiomics)

Pre-treatment MRI radiomics might identify non-responders to IMRT (AUC 0.78)

Different treatment options could be preferred for potential non-responders

Solari [52]

2021

Germany

RP

Prediction of GS upgrade from Bx

Retrospective, single-centre

101

[68Ga] Ga-PSMA-11 PET/MRI (radiomics)

Combined PET+ADC radiomics model outperformed Bx in the prediction of GS at RP (accuracy of 82.5% versus 72.4%)

More reliable patient risk stratification could be achieved to guide management

Cuocolo [59]

2021

Italy

RP

Detection of EPE

Retrospective, multi-centre

193

MRI (radiomics)

Radiomics model for EPE detection showed good generalizability in a multicentre setting and might aid radiologists in PCa staging

Low EPE probability at pre-treatment MRI might help select suitable candidates for nerve-sparing surgery

Zheng [67]

2022

USA

RP

Evaluation of lymph node involvement

Retrospective, single-centre

244

MRI (radiomics)

A combined model (clinical and radiomics features) outperformed pre-existing nomograms for the prediction of lymph node status (AUC 0.915 versus 0.724)

Reducing the number of unnecessary ePLND identifying patients with low probability of lymph node involvement

  1. AI Artificial intelligence, AUC Area under the receiver operating characteristic curve, Bx Biopsy, EPE Extraprostatic extension of disease, ePLND Extended pelvic lymph node dissection, GI Gastrointestinal, GS Gleason score, IMRT Intensity-modulated radiotherapy, MRIgRT MRI-guided radiotherapy, NTCP Logistic normal tissue complication probability, OARs Organs at risk, RO Radiation oncologist, RP Radical prostatectomy, RT Radiotherapy, TP Treatment planning